We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Electrophysiology – Products

Axol Bioscience Introduces Multi-Electrode Array Screening Services for Human iPSC-Derived Cells  content piece image
Product News

Axol Bioscience Introduces Multi-Electrode Array Screening Services for Human iPSC-Derived Cells

Axol Bioscience (Axol), a biotechnology company specializing in the use of stem cell technology, today announced the expansion of its service offering, with the introduction of multi-electrode array (MEA) screening for human induced pluripotent stem cell (hiPSC)-derived cells.
New Recommendations for Assessing the Cardiac Safety of New Medicines content piece image
Product News

New Recommendations for Assessing the Cardiac Safety of New Medicines

Metrion Biosciences has contributed to two new papers that focus on the application of improved cardiac safety testing protocols and recommendations for best practice for the drug discovery industry.
Using Machine Learning to Improve Management of Atrial Fibrillation content piece image
Product News

Using Machine Learning to Improve Management of Atrial Fibrillation

TTP has established a partnership with NHS Highland and The University of the Highlands and Islands to use clinical data interpretation and machine learning algorithms to predict which patients with atrial fibrillation are able to be successfully treated using electrical cardioversion.

New Biomarker of Parkinson’s Disease Progression content piece image
Product News

New Biomarker of Parkinson’s Disease Progression

SynapCell and Motac Neuroscience have discovered a new biomarker for monitoring the progression of Parkinson’s disease.
Accelerating Neuroscience-focused Ion Channel Drug Discovery  content piece image
Product News

Accelerating Neuroscience-focused Ion Channel Drug Discovery

Metrion and LifeArc have announced an extension of their neuroscience-focused ion channel drug discovery collaboration, following the success of the initial twelve-month agreement.
Ultima 2Pplus content piece image
Product
Advertisement

Ultima 2Pplus

fNIRS System for Brain Imaging Research content piece image
Product
Advertisement

fNIRS System for Brain Imaging Research

CellOPTIQ® High Content Assay Confirmed as Leader in Assessing Cardiotoxicity content piece image
Product News

CellOPTIQ® High Content Assay Confirmed as Leader in Assessing Cardiotoxicity

A major international FDA-led study confirms CellOPTIQ® High Content Assay as leading in vitro platform to assess cardiotoxicity in new drugs.
Metrion Biosciences and AMRI Collaborate to Offer Ion Channel Drug Discovery Services content piece image
Product News

Metrion Biosciences and AMRI Collaborate to Offer Ion Channel Drug Discovery Services

Agreement enables customers to access a broader range of drug discovery expertise.
Whitepaper

A Look at How a New B-27 Plus Formulation Improves Primary Neuron Survival and Neural Network Activity

Want to improve the reliability of your neuronal cell culture experiments by increasing survival of the neurons?
Advertisement